共 50 条
Antiphospholipid antibodies in 146 women with repeated pregnancy losses
被引:0
|作者:
Slama, FB
[1
]
Nagara, M
Slama, A
Jmili, NB
Monastiri, K
Laouani-Kechrid, C
Toumi, NH
N'Siri, B
Samama, M
Mahjoub, T
机构:
[1] CHU Farhat Hached, Immunol Lab, Sousse 4001, Tunisia
[2] CHU Farhat Hached, Hematol Lab, Sousse 4001, Tunisia
[3] CHU Farhat Hached, Ctr Matern & Neonatol, Sousse 4001, Tunisia
[4] CHU Farhat Hached, Serv Med Interne, Sousse 4001, Tunisia
[5] Hop Hotel Dieu, Serv Hematol Biol, F-75004 Paris, France
关键词:
antiphospholipid antibodies;
recurrent abortion;
fetal loss;
D O I:
暂无
中图分类号:
R446 [实验室诊断];
R-33 [实验医学、医学实验];
学科分类号:
1001 ;
摘要:
Antiphospholipid antibodies are associated with arterial and venous thrombosis and recurrent abortions. However, the prevalence of these antibodies in repeated miscarriages varies in different reports. To obtain quantitative data with restricted criteria and discuss the origin of the variability on the literature, we investigated the presence of anti phospholipid antibodies in 146 women who had 2 or more consecutive pregnancy losses and in 99 women whose pregnancies were successful. Antiphospholipid antibodies (lupus anticoagulant or anticardiolipin antibodies of 20 or more IgG units) were found in 45% of women with pregnancy losses and in 9% of controls (p < 0.001). The type of loss was determined according to the trimester of pregnancy and the time of the fetal loss. 68% of patients with antiphospholipid antibodies had at least one fetal loss on the second or third trimester compared with 45% of patients without fetal loss (p < 0.01). Further studies should be conducted using more rigorus definition of clinical and laboratory caracteristics in a way to allow better comparison between studies.
引用
下载
收藏
页码:217 / 221
页数:5
相关论文